Janssen’s quarterly schizophrenia drug approved in EU
Company hopes new formulation will improve patient outcomes.
X
Janssen’s quarterly schizophrenia drug approved in EU
https://pharmaphorum.com/news/janssens-quarterly-schizophrenia-drug-approved-in-eu/